Medindia

X

Award-Winning Actor Danny Glover Featured on 'Sharing Miracles'

Friday, October 23, 2009 General News J E 4
Advertisement

WASHINGTON, Oct. 23 /PRNewswire-USNewswire/ -- A recent edition of Immunotherapy Weekly reported that the television program 'Sharing Miracles' featured award-winning actor Danny Glover during the month of September. In this episode, the Hollywood star discussed his career and his battle against epilepsy.

Danny Glover is probably best known for his role as Detective Murtaugh in the Lethal Weapon movie series. Less known to his fans may be the fact that Glover struggled with epilepsy for 20 years.

Glover experienced his first epileptic seizure when he was 15 years old. Despite many tests, it wasn't until he suffered from several more seizures that he was diagnosed with epilepsy and treated with medication. Fortunately, Glover was able to control his illness and build an impressive acting career – appearing in dozens of movies including The Color Purple, Places in the Heart, The Royal Tenenbaums and Dreamgirls, among others.  

After 20 years, for reasons unknown, Glover stopped experiencing seizures. However, other epilepsy patients are not so lucky.

According to the Epilepsy Foundation, more than 2.5 million Americans suffer from the disease, with more than 108,000 diagnoses each year. Fortunately, America's pharmaceutical research and biotechnology companies have more than 540 medicines in development to treat debilitating neurological disorders such as epilepsy.

'Sharing Miracles' is a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients. Sharing Miracles airs every Sunday morning on more than 300 television stations nationwide. The program is produced by the Pharmaceutical Research and Manufacturers of America (PhRMA).

PhRMA represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives.

To read the original article in Immunotherapy Weekly, visit the publication's website.

SOURCE Pharmaceutical Research and Manufacturers of America

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Survey Shows Wide Acceptance for Capabilities of P...
S
Accelify Announces Enhancements to Missouri Produc...